StockData
GNVROTCAgricultural Production-CropsFiscal year ends September 30

Genvor Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.61−0.07 (-9.89%)

Close on Oct 19, 2026

Market cap
$22.19M
P/E (TTM)
–
Dividend yield
–

About Genvor

Agricultural Production-Crops, SIC 0100

Genvor Incorporated is an agricultural biotechnology company that develops peptide technologies to address challenges in crop protection, plant performance, and animal health. Utilizing an artificial intelligence platform called the BioCypher Algorithm, the company designs bioactive peptides, including antimicrobial peptides to combat bacterial, fungal, and viral plant pathogens, as well as nutritionally enhanced and crop-enhancing peptides to improve nutrient uptake and stress resilience. Genvor focuses on agricultural applications such as transgenic seed traits for major crops like corn, soybeans, and cotton, alongside topical foliar biopesticide sprays. It also explores animal nutrition applications to enhance feed efficiency in poultry, swine, and aquaculture. Its target customers and commercial partners include agricultural organizations and growers across conventional and organic markets.

The company operates primarily through research, development, and strategic partnerships, with patent filings extending internationally to Canada, Mexico, and China. Genvor maintains its principal executive offices and corporate headquarters in Henderson, Nevada.

Summary of the business section of Genvor's latest annual report, written by StockData.

Company profile

Company

Legal name
Genvor Inc
Founded
2018
Headquarters
Henderson, NV
Address
1550 W Horizon Ridge Pkwy, Ste R #3040 89012
Phone
(715) 903-6473
Employees
2, Sep 30, 2025
Industry
Agricultural Production-Crops
Incorporated in
Nevada
Fiscal year ends
September 30
Auditor
Novogradac & Company LLP, Plantation, Florida

Stock & identifiers

Ticker
GNVR
Exchange
OTC
Shares outstanding
36M, Aug 14, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1792941
EIN
83-2054746

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Chad Lee Pawlak Sr.Chief Executive Officer, Director7,000,000
Jessee M. JaynesChief Research Officer, Director524,000
Donald A. KalkofenChief Financial Officer–
Clayton Clopton YatesDirector400,000

Employees

Headcount reported in annual reports

“As of September 30, 2025, we had two full-time employees and two scientific employee advisors.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 13, 2025Late filingNotification of late filing
May 12, 2025Late filingNotification of late filing
Feb 18, 2025Late filingNotification of late filing
Jan 31, 2025Late filingNotification of late filing
Aug 15, 2024Late filingNotification of late filing
Mar 21, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 2, 2024Late filingNotification of late filing
Jun 15, 2022Name changeName changed from Allure Worldwide, Inc. to Genvor Inc
Jun 9, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 1, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)